Eli Lilly raised its full-year profit and revenue forecast on Thursday as strong appetite for its widely popular weight-loss ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.
Cipla Ltd (BOM:500087) reports an all-time high quarterly revenue, strategic biosimilar launch in the US, and revised EBITDA guidance amidst market challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results